Vaxcyte, Inc.
SEC Filing List
PCVX CIK: 0001649094
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 05/15/2026 | ||||
| 8-K | Current report filing | Vaxcyte, Inc. | 05/06/2026 | ||
| SCHEDULE 13G/A | 05/06/2026 | ||||
| 10-Q | Quarterly report pursuant to Section 13 ... | Vaxcyte, Inc. | 05/06/2026 | ||
| 4 | Statement of changes in beneficial owner... | Wassil Jim | Vaxcyte, Inc. | 05/01/2026 | |
| 144 | Filing for proposed sale of securities u... | UBS Financial Services Inc Restricted Sale Group / FA /fa | 05/01/2026 | ||
| SCHEDULE 13G | 04/30/2026 | ||||
| ARS | Annual report to security holders | Vaxcyte, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/23/2026 | |
| DEF 14A | Definitive proxy statements | Vaxcyte, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/23/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Vaxcyte, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/23/2026 | |
| No record found. | |||||
| Load More | |||||
